1994
DOI: 10.1016/0378-4347(94)00071-9
|View full text |Cite
|
Sign up to set email alerts
|

Assay for maprotiline in human serum with improved sensitivity and selectivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Such derivatives show antidepressant effects, being used for the treatment of disorders such as anxiety or as analgesics . The bicylo anthracene scaffold containing agent, 3‐(9,10‐dihydro‐9,10‐ethanoanthracene‐9‐yl) N ‐methylpropylamine (maprotiline) also shows antidepressant properties and imides incorporating this skeleton act as glucocorticoid receptor modulators .…”
Section: Introductionmentioning
confidence: 99%
“…Such derivatives show antidepressant effects, being used for the treatment of disorders such as anxiety or as analgesics . The bicylo anthracene scaffold containing agent, 3‐(9,10‐dihydro‐9,10‐ethanoanthracene‐9‐yl) N ‐methylpropylamine (maprotiline) also shows antidepressant properties and imides incorporating this skeleton act as glucocorticoid receptor modulators .…”
Section: Introductionmentioning
confidence: 99%
“…Re commended analytical methods for maprotiline in volve mainly GC in combination with a nitrogen phosphorus detector [4][5][6], HPLC with UV [7][8][9], di od array as well as fluorescence detectors [10][11][12], HPLC with chemiluminescence [13], spectophoto metric, spectrofluorimetric [1,14], and TLC [15]. Methods included in the United States Pharmacopoe ia and European Pharmacopoeia address only the analysis of maprotiline drug substance and tablets without impurities determination in solid dosage forms [16,17].…”
mentioning
confidence: 99%